May 14, 2013

Target Corporation (TGT) and Novartis AG (NVS) are two attractively-priced companies that have grown their dividends over the last 10 years, and both are strong plays to include in an equity portfolio, says Russell Sims, Portfolio Manager and Director of Research for Osborn Rohs Williams & Donohoe.

Target has, in the last 10 years, grown its dividend nearly 20%. It’s attractively priced and has great near-term fundamentals, so it really stands out in my mind as one of the top names in the portfolio,” said Sims.


Sims also recommends Novartis, who despite slower dividend growth, is paying a higher yield. These two companies are part of Sims’ dividend growth portfolio strategy, helping clients to maintain strong, growing dividend income.

Novartis is another terrific name. It’s grown its dividend a little slower, around 13%, over the last 10 years, but it pays a higher yield, it’s about a 3.3% dividend yield, and it’s also attractively priced,” Sims said.

Pin It on Pinterest

Share This